LeMaitre Vascular
LMAT
#4757
Rank
NZ$3.28 B
Marketcap
NZ$144.65
Share price
0.77%
Change (1 day)
-16.52%
Change (1 year)
Categories

P/E ratio for LeMaitre Vascular (LMAT)

P/E ratio as of December 2025 (TTM): 35.3

According to LeMaitre Vascular's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.3291. At the end of 2024 the company had a P/E ratio of 46.4.

P/E ratio history for LeMaitre Vascular from 2007 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202446.412.13%
202341.4-12.32%
202247.223.79%
202138.23.43%
202036.9-2.21%
201937.7101.6%
201818.7-42.9%
201732.8-19.83%
201640.914.6%
201535.719.61%
201429.8-6.96%
201332.19.74%
201229.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
AngioDynamics
ANGO
-17.1-148.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
48.7 37.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
35.8 1.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardiovascular Systems
CSII
-20.6-158.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
-17.3-149.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-29.0-182.09%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.